Cargando…
Corrigendum: Novel molecular therapeutics targeting signaling pathway to control hepatitis B viral infection
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402635/ https://www.ncbi.nlm.nih.gov/pubmed/37545856 http://dx.doi.org/10.3389/fcimb.2023.1253110 |
| _version_ | 1785084885553119232 |
|---|---|
| author | Yan, Yan Qiu, Yuanwang Davgadorj, Chantsalmaa Zheng, Chunfu |
| author_facet | Yan, Yan Qiu, Yuanwang Davgadorj, Chantsalmaa Zheng, Chunfu |
| author_sort | Yan, Yan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10402635 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104026352023-08-05 Corrigendum: Novel molecular therapeutics targeting signaling pathway to control hepatitis B viral infection Yan, Yan Qiu, Yuanwang Davgadorj, Chantsalmaa Zheng, Chunfu Front Cell Infect Microbiol Cellular and Infection Microbiology Frontiers Media S.A. 2023-07-21 /pmc/articles/PMC10402635/ /pubmed/37545856 http://dx.doi.org/10.3389/fcimb.2023.1253110 Text en Copyright © 2023 Yan, Qiu, Davgadorj and Zheng https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Cellular and Infection Microbiology Yan, Yan Qiu, Yuanwang Davgadorj, Chantsalmaa Zheng, Chunfu Corrigendum: Novel molecular therapeutics targeting signaling pathway to control hepatitis B viral infection |
| title | Corrigendum: Novel molecular therapeutics targeting signaling pathway to control hepatitis B viral infection |
| title_full | Corrigendum: Novel molecular therapeutics targeting signaling pathway to control hepatitis B viral infection |
| title_fullStr | Corrigendum: Novel molecular therapeutics targeting signaling pathway to control hepatitis B viral infection |
| title_full_unstemmed | Corrigendum: Novel molecular therapeutics targeting signaling pathway to control hepatitis B viral infection |
| title_short | Corrigendum: Novel molecular therapeutics targeting signaling pathway to control hepatitis B viral infection |
| title_sort | corrigendum: novel molecular therapeutics targeting signaling pathway to control hepatitis b viral infection |
| topic | Cellular and Infection Microbiology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402635/ https://www.ncbi.nlm.nih.gov/pubmed/37545856 http://dx.doi.org/10.3389/fcimb.2023.1253110 |
| work_keys_str_mv | AT yanyan corrigendumnovelmoleculartherapeuticstargetingsignalingpathwaytocontrolhepatitisbviralinfection AT qiuyuanwang corrigendumnovelmoleculartherapeuticstargetingsignalingpathwaytocontrolhepatitisbviralinfection AT davgadorjchantsalmaa corrigendumnovelmoleculartherapeuticstargetingsignalingpathwaytocontrolhepatitisbviralinfection AT zhengchunfu corrigendumnovelmoleculartherapeuticstargetingsignalingpathwaytocontrolhepatitisbviralinfection |